180 related articles for article (PubMed ID: 23207834)
1. Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.
Weber T; Ocheni S; Binder M; Theurich S; Scheid C; Schmid C; Müller LP; Christopeit M; Bacher U
Acta Haematol; 2013; 129(3):135-6. PubMed ID: 23207834
[No Abstract] [Full Text] [Related]
2. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patients.
Ramanarayanan J; Dunford LM; Baer MR; Sait SN; Lawrence W; McCarthy PL
Leuk Res; 2006 Jun; 30(6):701-5. PubMed ID: 16330096
[TBL] [Abstract][Full Text] [Related]
4. [Treatment outcome of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies not in remission].
Bao HY; Wu XJ; Ma X
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):156-7. PubMed ID: 22780938
[No Abstract] [Full Text] [Related]
5. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
6. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
[TBL] [Abstract][Full Text] [Related]
7. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
Rondelli D; Re F; Bandini G; Raspadori D; Arpinati M; Senese B; Stanzani M; Bonifazi F; Falcioni S; Chirumbolo G; Tura S
Bone Marrow Transplant; 2000 Dec; 26(12):1325-31. PubMed ID: 11223973
[TBL] [Abstract][Full Text] [Related]
8. [Indications, technique and risks in bone marrow transplantation in adulthood].
Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
[TBL] [Abstract][Full Text] [Related]
9. DLI or second transplant.
Greinix HT
Ann Hematol; 2002; 81 Suppl 2():S34-5. PubMed ID: 12611068
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous acute myeloid leukemia and multiple myeloma successfully treated with allogeneic stem cell transplantation.
Kim D; Kwok B; Steinberg A
South Med J; 2010 Dec; 103(12):1246-9. PubMed ID: 21037523
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
Saito T; Kanda Y; Kami M; Kato K; Shoji N; Kanai S; Ohnishi T; Kawano Y; Nakai K; Ogasawara T; Matsubara H; Makimoto A; Tanosaki R; Tobinai K; Wakasugi H; Takaue Y; Mineishi S
Clin Cancer Res; 2002 Apr; 8(4):1014-20. PubMed ID: 11948108
[TBL] [Abstract][Full Text] [Related]
13. Re-emerging Philadelphia chromosome-positive acute leukaemia more than 20 years after allogeneic haematopoietic stem cell transplantation.
Kodama Y; Okamura J; Fukano R; Nakashima K; Ito N; Nishimura M; Abe Y; Suzuki T; Inagaki J
Br J Haematol; 2013 Apr; 161(2):286-9. PubMed ID: 23294201
[No Abstract] [Full Text] [Related]
14. Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy.
Kawashima N; Inamoto Y; Sato T; Nakashima M; Kagaya Y; Watakabe K; Seto A; Fukushima N; Kurahashi S; Ozawa Y; Miyamura K
Bone Marrow Transplant; 2016 Jun; 51(6):869-71. PubMed ID: 26878661
[No Abstract] [Full Text] [Related]
15. Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation.
Bornhauser M; Thiede C; Babatz J; Schetelig J; Illmer T; Kiani A; Platzbecker U; Herr W; Rieber EP; Ehninger G; Schmitz M
Leukemia; 2006 Nov; 20(11):2055-7. PubMed ID: 16990776
[No Abstract] [Full Text] [Related]
16. Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage.
Chaidos A; Kanfer E; Apperley JF
Best Pract Res Clin Haematol; 2007 Jun; 20(2):125-54. PubMed ID: 17448953
[TBL] [Abstract][Full Text] [Related]
17. [Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results].
Schmid C; Weisser M; Ledderose G; Stötzer O; Schleuning M; Kolb HJ
Dtsch Med Wochenschr; 2002 Oct; 127(42):2186-92. PubMed ID: 12397547
[TBL] [Abstract][Full Text] [Related]
18. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
[TBL] [Abstract][Full Text] [Related]
19. Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: outcome and prognostic factors: the Chronic Myeloid Leukemia Subcommittee of the GETH (Grupo Español de Trasplante Hemopoyético).
Martínez C; Gomez V; Tomás JF; Parody R; Sureda A; Sanz G; Cañizo C; Díez JL; Boqué C;
Bone Marrow Transplant; 2005 Aug; 36(4):301-6. PubMed ID: 15968278
[TBL] [Abstract][Full Text] [Related]
20. [Non-myeloablative allogeneic stem cell transplantation].
Dalgaard J; Fløisand Y; Stenersen M; Egeland T; Brinch L
Tidsskr Nor Laegeforen; 2007 Mar; 127(6):721-4. PubMed ID: 17363982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
